Critical Path Institute (C-Path) is thrilled to announce its Polycystic Kidney Disease Outcomes Consortium (PKDOC) has been awarded an Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) ...
Please provide your email address to receive an email when new articles are posted on . From an enrollment of more than 5 million, crude prevalence of autosomal dominant polycystic kidney disease was ...
Please provide your email address to receive an email when new articles are posted on . Nephrectomy can be effectively performed in patients with autosomal dominant PKD for various indications, such ...
People with autosomal dominant polycystic kidney disease (ADPKD) are at a high risk of developing kidney failure during their lives. Although there are many strategies that can be used to help reduce ...
Liver cysts were found in over 80% of patients with ADPKD but were not associated with chronic kidney disease stage, Mayo classification, PKD1 or PKD2 genotype variant, liver enzyme levels, or quality ...
A team of 10 U.S.-based investigators delved deeper into how autosomal dominant polycystic kidney disease affects patients’ health-related quality of life and pain levels. Here’s what they found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback